[A case of advanced gastric cancer remarkably responding to preoperative UFT-E therapy]. 1996

R Iwazaki, and K Maehiro, and K Iijima, and K Ota, and Y Ono, and K Sato, and R Okura, and H Miwa, and N Sato, and N Mizobuchi, and M Urabe, and R Wada
Department of Gastroenterology, Juntendo University School of Medicine, Japan.

We here reported a case of advanced gastric cancer remarkably responding to preoperative short-term UFT-E chemotherapy. UFT-E was orally administered preoperatively for about a month to the patient with type 2 advanced gastric cancer. After the chemotherapy the cancer was found to be remarkably decreased in size and denatured. The amount of residual cancer cells was limited by histopathological examination following the operation and diagnosed as Grade 3 based on the criteria of histological evaluation of chemotherapy for cancer. We continued to administer UFT-E postoperatively and the patient is still alive without symptoms.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005641 Tegafur Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms. 1-(2-Tetrahydrofuryl)-5-fluorouracil,1-(Tetrahydro-2-furanyl)-5-fluorouracil,5-Fluoro-1-(tetrahydro-2-furanyl)-2,4-pyrimidinedione,FT-207,FT207,Florafur,Fluorofur,Ftorafur,Futraful,N1-(2'-Tetrahydrofuryl)-5-fluorouracil,Sunfural S,Uftoral,Utefos,FT 207
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D014498 Uracil One of four nucleotide bases in the nucleic acid RNA.

Related Publications

R Iwazaki, and K Maehiro, and K Iijima, and K Ota, and Y Ono, and K Sato, and R Okura, and H Miwa, and N Sato, and N Mizobuchi, and M Urabe, and R Wada
May 1997, Gan to kagaku ryoho. Cancer & chemotherapy,
R Iwazaki, and K Maehiro, and K Iijima, and K Ota, and Y Ono, and K Sato, and R Okura, and H Miwa, and N Sato, and N Mizobuchi, and M Urabe, and R Wada
October 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
R Iwazaki, and K Maehiro, and K Iijima, and K Ota, and Y Ono, and K Sato, and R Okura, and H Miwa, and N Sato, and N Mizobuchi, and M Urabe, and R Wada
June 1993, Gan to kagaku ryoho. Cancer & chemotherapy,
R Iwazaki, and K Maehiro, and K Iijima, and K Ota, and Y Ono, and K Sato, and R Okura, and H Miwa, and N Sato, and N Mizobuchi, and M Urabe, and R Wada
August 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
R Iwazaki, and K Maehiro, and K Iijima, and K Ota, and Y Ono, and K Sato, and R Okura, and H Miwa, and N Sato, and N Mizobuchi, and M Urabe, and R Wada
January 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
R Iwazaki, and K Maehiro, and K Iijima, and K Ota, and Y Ono, and K Sato, and R Okura, and H Miwa, and N Sato, and N Mizobuchi, and M Urabe, and R Wada
April 2001, Gan to kagaku ryoho. Cancer & chemotherapy,
R Iwazaki, and K Maehiro, and K Iijima, and K Ota, and Y Ono, and K Sato, and R Okura, and H Miwa, and N Sato, and N Mizobuchi, and M Urabe, and R Wada
December 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
R Iwazaki, and K Maehiro, and K Iijima, and K Ota, and Y Ono, and K Sato, and R Okura, and H Miwa, and N Sato, and N Mizobuchi, and M Urabe, and R Wada
December 1998, Gan to kagaku ryoho. Cancer & chemotherapy,
R Iwazaki, and K Maehiro, and K Iijima, and K Ota, and Y Ono, and K Sato, and R Okura, and H Miwa, and N Sato, and N Mizobuchi, and M Urabe, and R Wada
January 1988, Gan to kagaku ryoho. Cancer & chemotherapy,
R Iwazaki, and K Maehiro, and K Iijima, and K Ota, and Y Ono, and K Sato, and R Okura, and H Miwa, and N Sato, and N Mizobuchi, and M Urabe, and R Wada
March 1995, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!